首页 > 最新文献

La radiologia medica最新文献

英文 中文
MRI diagnostic performance and strategies for identifying retears in treated pediatric discoid and non-discoid lateral meniscal repairs 核磁共振成像诊断性能和策略,用于识别经治疗的小儿盘状和非盘状外侧半月板修复术中的再撕裂情况
Pub Date : 2024-09-18 DOI: 10.1007/s11547-024-01884-x
Jason Zarahi Amaral, Rida Salman, Scott D. McKay, J. Herman Kan

Magnetic resonance imaging (MRI) plays a role in assessing retears of previously treated lateral menisci (LM). We aim to characterize the rate and pattern of arthroscopically confirmed LM retears in children with and without discoid morphology. 288 patients (312 knees) who underwent arthroscopic repair of isolated LM tears between 2018 and 2023 were identified. 20 patients (21 knees) had arthroscopically confirmed isolated LM retear. This included 11 retears of discoid lateral meniscus (DLM) and 10 retears of non-DLM. MRI correctly identified retear in 81.8% of DLM cases (n = 9) and 100% of non-DLM cases (overall 90.5%, P = 0.476). 78% of DLM cases (n = 7) had residual discoid elements. MRI is highly accurate in diagnosing retears in isolated LM injuries (90.5%). We suggest that the radiological approach to assessing meniscal retears can be similarly applied to treated discoid and non-discoid menisci. However, special attention to residual discoid elements is crucial in previously treated DLMs.

磁共振成像(MRI)在评估先前治疗过的外侧半月板(LM)的再撕裂情况中发挥着作用。我们的目的是描述有盘状形态和无盘状形态的儿童中经关节镜证实的LM再撕裂率和模式。我们对2018年至2023年期间接受关节镜修复孤立LM撕裂的288名患者(312个膝关节)进行了鉴定。20名患者(21个膝关节)经关节镜确诊为孤立LM再撕裂。其中包括11例盘状外侧半月板(DLM)再撕裂和10例非DLM再撕裂。磁共振成像正确识别出81.8%的DLM病例(n = 9)和100%的非DLM病例(总体90.5%,P = 0.476)存在再撕裂。78%的 DLM 病例(7 例)有残留的盘状元素。磁共振成像在诊断孤立的 LM 损伤(90.5%)时非常准确。我们认为,评估半月板再撕裂的放射学方法同样适用于经过治疗的盘状和非盘状半月板。然而,在先前治疗过的DLM中,特别注意残留的盘状元素至关重要。
{"title":"MRI diagnostic performance and strategies for identifying retears in treated pediatric discoid and non-discoid lateral meniscal repairs","authors":"Jason Zarahi Amaral, Rida Salman, Scott D. McKay, J. Herman Kan","doi":"10.1007/s11547-024-01884-x","DOIUrl":"https://doi.org/10.1007/s11547-024-01884-x","url":null,"abstract":"<p>Magnetic resonance imaging (MRI) plays a role in assessing retears of previously treated lateral menisci (LM). We aim to characterize the rate and pattern of arthroscopically confirmed LM retears in children with and without discoid morphology. 288 patients (312 knees) who underwent arthroscopic repair of isolated LM tears between 2018 and 2023 were identified. 20 patients (21 knees) had arthroscopically confirmed isolated LM retear. This included 11 retears of discoid lateral meniscus (DLM) and 10 retears of non-DLM. MRI correctly identified retear in 81.8% of DLM cases (n = 9) and 100% of non-DLM cases (overall 90.5%, <i>P</i> = 0.476). 78% of DLM cases (n = 7) had residual discoid elements. MRI is highly accurate in diagnosing retears in isolated LM injuries (90.5%). We suggest that the radiological approach to assessing meniscal retears can be similarly applied to treated discoid and non-discoid menisci. However, special attention to residual discoid elements is crucial in previously treated DLMs.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"116 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid artery assessment in dual-source photon-counting CT: impact of low-energy virtual monoenergetic imaging on image quality, vascular contrast and diagnostic assessability 双源光子计数 CT 中的颈动脉评估:低能量虚拟单能成像对图像质量、血管对比度和诊断可评估性的影响
Pub Date : 2024-09-17 DOI: 10.1007/s11547-024-01889-6
Christian Booz, Giuseppe M. Bucolo, Tommaso D’Angelo, Silvio Mazziotti, Ludovica R. M. Lanzafame, Ibrahim Yel, Leona S. Alizadeh, Leon D. Gruenewald, Vitali Koch, Simon S. Martin, Mirela Dimitrova, Aynur Goekduman, Thomas J. Vogl, Hanns L. Kaatsch, Daniel Overhoff, Stephan Waldeck

Purpose

Preliminary dual-energy CT studies have shown that low-energy virtual monoenergetic (VMI) + reconstructions can provide superior image quality compared to standard 120 kV CTA series. The purpose of this study is to evaluate the impact of low-energy VMI reconstructions on quantitative and qualitative image quality, vascular contrast, and diagnostic assessability of the carotid artery in patients undergoing photon-counting CTA examinations.

Materials and methods

A total of 122 patients (67 male) who had undergone dual-source photon-counting CTA scans of the carotid artery were retrospectively analyzed in this study. Standard 120 kV CT images and low-keV VMI series from 40 to 100 keV with an interval of 15 keV were reconstructed. Quantitative analyses included the evaluation of vascular CT numbers, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). CT number measurements were performed in the common, external, and internal carotid arteries. Qualitative analyses were performed by three board-certified radiologists independently using five-point scales to evaluate image quality, vascular contrast, and diagnostic assessability of the carotid artery.

Results

Mean attenuation, CNR and SNR values were highest in 40 keV VMI reconstructions (HU, 1362.32 ± 457.81; CNR, 33.19 ± 12.86; SNR, 34.37 ± 12.89) followed by 55-keV VMI reconstructions (HU, 736.94 ± 150.09; CNR, 24.49 ± 7.11; SNR, 26.25 ± 7.34); all three mean values at these keV levels were significantly higher compared with the remaining VMI series and standard 120 kV CT series (HU, 154.43 ± 23.69; CNR, 16.34 ± 5.47; SNR, 24.44 ± 7.14) (p < 0.0001).

The qualitative analysis showed the highest rating scores for 55 keV VMI reconstructions followed by 40 keV and 70 keV VMI series with a significant difference compared to standard 120 kV CT images series regarding image quality, vascular contrast, and diagnostic assessability of the carotid artery (all comparisons, p < 0.01).

Conclusions

Low-keV VMI reconstructions at a level of 40–55 keV significantly improve image quality, vascular contrast, and the diagnostic assessability of the carotid artery compared with standard CT series in photon-counting CTA.

目的初步的双能量 CT 研究表明,与标准 120 kV CTA 系列相比,低能量虚拟单能量(VMI)+ 重建可提供更优越的图像质量。本研究的目的是评估低能量 VMI 重建对接受光子计数 CTA 检查的患者颈动脉定量和定性图像质量、血管对比度和诊断可评估性的影响。材料和方法本研究对接受颈动脉双源光子计数 CTA 扫描的 122 名患者(67 名男性)进行了回顾性分析。重建了标准 120 kV CT 图像和 40 至 100 keV、间隔 15 keV 的低 keV VMI 系列图像。定量分析包括评估血管 CT 数量、信噪比 (SNR) 和对比度与噪声比 (CNR)。对颈总动脉、颈外动脉和颈内动脉进行了 CT 数量测量。定性分析由三位经委员会认证的放射科医生独立完成,采用五点评分法评估图像质量、血管对比度和颈动脉的诊断评估能力。结果 40 keV VMI 重建的平均衰减、CNR 和 SNR 值最高(HU, 1362.32 ± 457.81;CNR,33.19 ± 12.86;SNR,34.37 ± 12.89),其次是 55-keV VMI 重建(HU,736.94 ± 150.09;CNR,24.49 ± 7.11;SNR,26.25 ± 7.34);与其余 VMI 系列和标准 120 kV CT 系列相比,这些 keV 水平的所有三个平均值都明显更高(HU,154.43 ± 23.定性分析显示,55 keV VMI 重建的评分最高,其次是 40 keV 和 70 keV VMI 系列,在图像质量、血管对比度和颈动脉的诊断评估性方面与标准 120 kV CT 图像系列相比有显著差异(所有比较,p < 0.结论与光子计数 CTA 中的标准 CT 系列相比,40-55 千伏的低千伏 VMI 重建能显著提高图像质量、血管对比度和颈动脉的诊断评估能力。
{"title":"Carotid artery assessment in dual-source photon-counting CT: impact of low-energy virtual monoenergetic imaging on image quality, vascular contrast and diagnostic assessability","authors":"Christian Booz, Giuseppe M. Bucolo, Tommaso D’Angelo, Silvio Mazziotti, Ludovica R. M. Lanzafame, Ibrahim Yel, Leona S. Alizadeh, Leon D. Gruenewald, Vitali Koch, Simon S. Martin, Mirela Dimitrova, Aynur Goekduman, Thomas J. Vogl, Hanns L. Kaatsch, Daniel Overhoff, Stephan Waldeck","doi":"10.1007/s11547-024-01889-6","DOIUrl":"https://doi.org/10.1007/s11547-024-01889-6","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Preliminary dual-energy CT studies have shown that low-energy virtual monoenergetic (VMI) + reconstructions can provide superior image quality compared to standard 120 kV CTA series. The purpose of this study is to evaluate the impact of low-energy VMI reconstructions on quantitative and qualitative image quality, vascular contrast, and diagnostic assessability of the carotid artery in patients undergoing photon-counting CTA examinations.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>A total of 122 patients (67 male) who had undergone dual-source photon-counting CTA scans of the carotid artery were retrospectively analyzed in this study. Standard 120 kV CT images and low-keV VMI series from 40 to 100 keV with an interval of 15 keV were reconstructed. Quantitative analyses included the evaluation of vascular CT numbers, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR). CT number measurements were performed in the common, external, and internal carotid arteries. Qualitative analyses were performed by three board-certified radiologists independently using five-point scales to evaluate image quality, vascular contrast, and diagnostic assessability of the carotid artery.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Mean attenuation, CNR and SNR values were highest in 40 keV VMI reconstructions (HU, 1362.32 ± 457.81; CNR, 33.19 ± 12.86; SNR, 34.37 ± 12.89) followed by 55-keV VMI reconstructions (HU, 736.94 ± 150.09; CNR, 24.49 ± 7.11; SNR, 26.25 ± 7.34); all three mean values at these keV levels were significantly higher compared with the remaining VMI series and standard 120 kV CT series (HU, 154.43 ± 23.69; CNR, 16.34 ± 5.47; SNR, 24.44 ± 7.14) (<i>p</i> &lt; 0.0001).</p><p>The qualitative analysis showed the highest rating scores for 55 keV VMI reconstructions followed by 40 keV and 70 keV VMI series with a significant difference compared to standard 120 kV CT images series regarding image quality, vascular contrast, and diagnostic assessability of the carotid artery (all comparisons, <i>p</i> &lt; 0.01).</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Low-keV VMI reconstructions at a level of 40–55 keV significantly improve image quality, vascular contrast, and the diagnostic assessability of the carotid artery compared with standard CT series in photon-counting CTA.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142268571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response from a multicentric Italian retrospective study 针对 3 厘米以上肝脏恶性肿瘤的经皮热分段切除术:意大利一项多中心回顾性研究的中期肿瘤学表现和持续完全缓解的预测因素
Pub Date : 2024-09-16 DOI: 10.1007/s11547-024-01877-w
Pierleone Lucatelli, Bianca Rocco, Renato Argirò, Vittorio Semeraro, Quirino Lai, Elena Bozzi, Sara Crociati, Michele Barone, Alessandro Posa, Carlo Catalano, Laura Crocetti, Roberto Iezzi

Introduction

Percutaneous thermal segmentectomy is a single-step combination of microwave ablation, performed during arterial occlusion obtained with a balloon micro catheter, followed in the same session by balloon-occluded TACE. The aim of this multicenter retrospective study is to report the mid-term oncological performance of this technique for liver malignancies > 3.0 cm and to identify risk factors for the loss of sustained complete response.

Methods

Oncological results were evaluated with CT or MRI according to m-RECIST (HCC) and RECISTv1.1 (metastasis/intra-hepatic cholangiocarcinoma, iCC) at 1-month, 3–6-month and then at regular-6-month intervals. To identify predictive variables associated with not achieving or losing complete response two mixed-effects multivariable logistic regression models were constructed.

Results

Sixty-three patients (40/23, male/female) with primary liver malignancies (HCC = 49; iCC = 4) and metastasis (n = 10) were treated. Median diameter of target lesion was 4.5 cm (range 3.0–7.0 cm). The median follow-up time was 9.2 months. At one-month follow-up, 79.4% of patients presented with a complete response and the remaining 20.6% were partial responders. At the 3–6-month follow-up, reached by 59 of the initial 63 patients, 83.3% showed a sustained complete response, while 10.2% had a partial response and 8.5% a local recurrence. At the last follow-up, 69.8% of the lesions showed a complete response. The initial diameter of the target lesion ≥ 5.0 cm was the only independent variable associated with the risk of failure in maintaining a complete response at 6 months (OR = 8.58, 95% CI 1.38–53.43; P = 0.02).

Conclusion

Percutaneous thermal segmentectomy achieves promising oncological results in patients with tumors > 3.0 cm, with tumor dimension ≥ 5.0 cm being the only risk factor associated with the failure of a sustained complete response.

导言经皮热段切除术是在使用球囊微导管进行动脉闭塞期间实施微波消融的单步组合术,然后在同一疗程中进行球囊闭塞TACE。这项多中心回顾性研究的目的是报告该技术治疗 3.0 厘米肝脏恶性肿瘤的中期肿瘤学表现,并确定失去持续完全反应的风险因素。方法根据 m-RECIST(HCC)和 RECISTv1.1(转移瘤/肝内胆管癌,iCC)标准,分别在 1 个月、3-6 个月和 6 个月的间隔时间内通过 CT 或 MRI 评估肿瘤学结果。为了确定与未达到或失去完全应答相关的预测变量,我们构建了两个混合效应多变量逻辑回归模型。结果63名原发性肝脏恶性肿瘤(HCC=49;iCC=4)和转移瘤(n=10)患者(40/23,男性/女性)接受了治疗。靶病灶的中位直径为 4.5 厘米(范围为 3.0-7.0 厘米)。中位随访时间为 9.2 个月。在一个月的随访中,79.4%的患者完全应答,其余20.6%为部分应答。在 3-6 个月的随访中,最初的 63 名患者中有 59 人出现了持续的完全反应,83.3% 的患者出现了部分反应,10.2% 的患者出现了局部复发,8.5% 的患者出现了局部复发。在最后一次随访中,69.8%的病灶显示出完全反应。靶病灶初始直径≥5.0厘米是与6个月时未能维持完全反应的风险相关的唯一独立变量(OR = 8.58,95% CI 1.38-53.43;P = 0.02)。结论经皮热分段切除术在肿瘤≥3.0厘米的患者中取得了良好的肿瘤学效果,肿瘤尺寸≥5.0厘米是与未能维持完全反应相关的唯一风险因素。
{"title":"Percutaneous thermal segmentectomy for liver malignancies over 3 cm: mid-term oncological performance and predictors of sustained complete response from a multicentric Italian retrospective study","authors":"Pierleone Lucatelli, Bianca Rocco, Renato Argirò, Vittorio Semeraro, Quirino Lai, Elena Bozzi, Sara Crociati, Michele Barone, Alessandro Posa, Carlo Catalano, Laura Crocetti, Roberto Iezzi","doi":"10.1007/s11547-024-01877-w","DOIUrl":"https://doi.org/10.1007/s11547-024-01877-w","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Percutaneous thermal segmentectomy is a single-step combination of microwave ablation, performed during arterial occlusion obtained with a balloon micro catheter, followed in the same session by balloon-occluded TACE. The aim of this multicenter retrospective study is to report the mid-term oncological performance of this technique for liver malignancies &gt; 3.0 cm and to identify risk factors for the loss of sustained complete response.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Oncological results were evaluated with CT or MRI according to m-RECIST (HCC) and RECISTv1.1 (metastasis/intra-hepatic cholangiocarcinoma, iCC) at 1-month, 3–6-month and then at regular-6-month intervals. To identify predictive variables associated with not achieving or losing complete response two mixed-effects multivariable logistic regression models were constructed.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Sixty-three patients (40/23, male/female) with primary liver malignancies (HCC = 49; iCC = 4) and metastasis (n = 10) were treated. Median diameter of target lesion was 4.5 cm (range 3.0–7.0 cm). The median follow-up time was 9.2 months. At one-month follow-up, 79.4% of patients presented with a complete response and the remaining 20.6% were partial responders. At the 3–6-month follow-up, reached by 59 of the initial 63 patients, 83.3% showed a sustained complete response, while 10.2% had a partial response and 8.5% a local recurrence. At the last follow-up, 69.8% of the lesions showed a complete response. The initial diameter of the target lesion ≥ 5.0 cm was the only independent variable associated with the risk of failure in maintaining a complete response at 6 months (OR = 8.58, 95% CI 1.38–53.43; <i>P</i> = 0.02).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Percutaneous thermal segmentectomy achieves promising oncological results in patients with tumors &gt; 3.0 cm, with tumor dimension ≥ 5.0 cm being the only risk factor associated with the failure of a sustained complete response.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between incidental perirenal fat stranding on CT and metabolic syndrome in otherwise healthy adults CT 上偶然出现的肾周脂肪滞留与健康成年人代谢综合征之间的关系
Pub Date : 2024-09-11 DOI: 10.1007/s11547-024-01888-7
Dawon Park, Chansik An, Jeong-Sik Yu

Purpose

To investigate the association between metabolic syndrome and perirenal fat stranding (PRFS), which is defined as linear or curvilinear soft tissue densities in the perirenal fat on computed tomography (CT).

Material and Methods

Adults who had abdominal CT for health screening at a single institution between October 2022 and March 2023 were included retrospectively. Two radiologists assessed the extent of PRFS for each CT and graded it as absent, mild/moderate, and severe. Logistic regression analyses were used to investigate the associations between PRFS and metabolic syndrome-related factors, as well as age and gender.

Results

Among 701 participants (mean age, 56.8 years ± 9.7; 336 women and 365 men), 87 (12.4%) had mild (n = 80) or moderate (n = 7) PRFS. None had severe PRFS. The presence of PRFS was independently associated with higher body mass index (odds ratio [OR], 2.561 and 9.842 for overweight and obese, respectively; p ≤ 0.001), elevated blood pressure with or without anti-hypertensive medication (OR, 2.232; p = 0.015), anti-diabetic medication (OR, 3.129; p < 0.001), and lipid-lowering medication (OR, 1.919; p = 0.019), older age (OR, 4.545 and 9.109 for 50–59 years and ≥ 60 years, respectively; p ≤ 0.002), and male gender (OR, 10.065; p < 0.001). Sixty three of 87 (72.4%) participants with PRFS had metabolic syndrome, while 265 of 614 (43.2%) participants without PRFS did (p < 0.001).

Conclusion

Incidental mild or moderate PRFS may be associated with the presence of metabolic syndrome or related disorders in otherwise healthy adults.

材料与方法回顾性纳入 2022 年 10 月至 2023 年 3 月期间在一家机构接受腹部 CT 健康检查的成人。两名放射科医生对每张 CT 的 PRFS 范围进行评估,并将其分为无、轻度/中度和重度。结果在 701 名参与者(平均年龄为 56.8 岁 ± 9.7 岁;女性 336 人,男性 365 人)中,有 87 人(12.4%)患有轻度(n = 80)或中度(n = 7)PRFS。没有人患有重度 PRFS。PRFS 的存在与体重指数较高(超重和肥胖的几率比 [OR],分别为 2.561 和 9.842;P ≤ 0.001)、服用或未服用抗高血压药物的血压升高(OR,2.232;P = 0.015)、抗糖尿病药物(OR,3.129;p <;0.001)和降脂药物(OR,1.919;p = 0.019)、年龄较大(50-59 岁和≥60 岁的 OR 分别为 4.545 和 9.109;p ≤ 0.002)和男性(OR,10.065;p <;0.001)。87名有PRFS的参与者中有63人(72.4%)患有代谢综合征,而614名没有PRFS的参与者中有265人(43.2%)患有代谢综合征(p < 0.001)。
{"title":"Association between incidental perirenal fat stranding on CT and metabolic syndrome in otherwise healthy adults","authors":"Dawon Park, Chansik An, Jeong-Sik Yu","doi":"10.1007/s11547-024-01888-7","DOIUrl":"https://doi.org/10.1007/s11547-024-01888-7","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>To investigate the association between metabolic syndrome and perirenal fat stranding (PRFS), which is defined as linear or curvilinear soft tissue densities in the perirenal fat on computed tomography (CT).</p><h3 data-test=\"abstract-sub-heading\">Material and Methods</h3><p>Adults who had abdominal CT for health screening at a single institution between October 2022 and March 2023 were included retrospectively. Two radiologists assessed the extent of PRFS for each CT and graded it as absent, mild/moderate, and severe. Logistic regression analyses were used to investigate the associations between PRFS and metabolic syndrome-related factors, as well as age and gender.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Among 701 participants (mean age, 56.8 years ± 9.7; 336 women and 365 men), 87 (12.4%) had mild (<i>n</i> = 80) or moderate (<i>n</i> = 7) PRFS. None had severe PRFS. The presence of PRFS was independently associated with higher body mass index (odds ratio [OR], 2.561 and 9.842 for overweight and obese, respectively; <i>p</i> ≤ 0.001), elevated blood pressure with or without anti-hypertensive medication (OR, 2.232; <i>p</i> = 0.015), anti-diabetic medication (OR, 3.129; <i>p</i> &lt; 0.001), and lipid-lowering medication (OR, 1.919; <i>p</i> = 0.019), older age (OR, 4.545 and 9.109 for 50–59 years and ≥ 60 years, respectively; <i>p</i> ≤ 0.002), and male gender (OR, 10.065; <i>p</i> &lt; 0.001). Sixty three of 87 (72.4%) participants with PRFS had metabolic syndrome, while 265 of 614 (43.2%) participants without PRFS did (<i>p</i> &lt; 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Incidental mild or moderate PRFS may be associated with the presence of metabolic syndrome or related disorders in otherwise healthy adults.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"130 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of stress CMR and SPECT-MPI in patients undergoing intermediate-to-high-risk non-cardiac surgery 压力 CMR 和 SPECT-MPI 对中高风险非心脏手术患者的预后价值
Pub Date : 2024-09-10 DOI: 10.1007/s11547-024-01876-x
Fabio Fazzari, Costanza Lisi, Federica Catapano, Francesco Cannata, Federica Brilli, Stefano Figliozzi, Renato Maria Bragato, Giulio Giuseppe Stefanini, Lorenzo Monti, Marco Francone

Purpose

The objective of this study was to investigate the role of myocardial perfusion imaging (MPI) stress tests using stress cardiac magnetic resonance (sCMR) and single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in non-cardiac surgery (NCS) pre-operatory management.

Materials and methods

This monocentric retrospective study enrolled patients with coronary artery disease or a minimum of two cardiovascular risk factors undergoing intermediate-to-high-risk non-cardiac surgeries. The primary composite endpoint comprised cardiac death, cardiogenic shock, acute coronary syndromes (ACS), and cardiogenic pulmonary edema occurring within 30 days after surgery, while the secondary endpoint was ACS.

Results

A total of 1590 patients were enrolled; among them, 669 underwent a MPI stress test strategy (sCMR: 287, SPECT-MPI: 382). The incidence of 30-day cardiac events was lower in the stress-tested group compared to the non-stress-tested group (1.2% vs. 3.4%; p 0.006). Adopting a stress test strategy showed a significant reduction in the risk of the composite endpoint (OR: 0.33, 95% CI: 0.15–0.76, p 0.009) and ACS (OR: 0.41, 95% CI: 0.17–0.98, p 0.046) at multivariable analysis, with similar cardiac events rate between stress CMR and SPECT (1.1% vs. 1.3%, p 0.756). Stress CMR showed a greater accuracy to predict coronary artery revascularizations (sCMR c-statistic: 0.95, ischemic cut-point: 5.5%; SPECT c-statistic: 0.85, ischemic cut-point: 7.5%).

Conclusion

Stress test strategy is related to a lower occurrence of cardiac events in high-risk patients scheduled for intermediate-to-high-risk non-cardiac surgeries. Both sCMR and SPECT-MPI comparably reduce the likelihood of cardiac complications, albeit sCMR offers greater accuracy in predicting coronary artery revascularization.

本研究旨在探讨使用应激心脏磁共振(sCMR)和单光子发射计算机断层扫描心肌灌注成像(SPECT-MPI)进行心肌灌注成像(MPI)应激试验在非心脏手术(NCS)术前管理中的作用。主要复合终点包括术后 30 天内发生的心源性死亡、心源性休克、急性冠状动脉综合征(ACS)和心源性肺水肿,次要终点为 ACS。结果 共纳入 1590 名患者,其中 669 人接受了 MPI 压力测试策略(sCMR:287 人,SPECT-MPI:382 人)。与非压力测试组相比,压力测试组的 30 天心脏事件发生率较低(1.2% 对 3.4%;P 0.006)。多变量分析显示,采用压力测试策略可显著降低复合终点(OR:0.33,95% CI:0.15-0.76,P 0.009)和 ACS(OR:0.41,95% CI:0.17-0.98,P 0.046)的风险,压力 CMR 和 SPECT 的心脏事件发生率相似(1.1% 对 1.3%,P 0.756)。应激 CMR 预测冠状动脉血运重建的准确性更高(sCMR c 统计量:0.95,缺血切点:5.5%;SPECT c 统计量:0.85,缺血切点:7.5%)。sCMR和SPECT-MPI都能有效降低心脏并发症的发生率,但sCMR在预测冠状动脉血运重建方面更为准确。
{"title":"Prognostic value of stress CMR and SPECT-MPI in patients undergoing intermediate-to-high-risk non-cardiac surgery","authors":"Fabio Fazzari, Costanza Lisi, Federica Catapano, Francesco Cannata, Federica Brilli, Stefano Figliozzi, Renato Maria Bragato, Giulio Giuseppe Stefanini, Lorenzo Monti, Marco Francone","doi":"10.1007/s11547-024-01876-x","DOIUrl":"https://doi.org/10.1007/s11547-024-01876-x","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>The objective of this study was to investigate the role of myocardial perfusion imaging (MPI) stress tests using stress cardiac magnetic resonance (sCMR) and single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in non-cardiac surgery (NCS) pre-operatory management.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>This monocentric retrospective study enrolled patients with coronary artery disease or a minimum of two cardiovascular risk factors undergoing intermediate-to-high-risk non-cardiac surgeries. The primary composite endpoint comprised cardiac death, cardiogenic shock, acute coronary syndromes (ACS), and cardiogenic pulmonary edema occurring within 30 days after surgery, while the secondary endpoint was ACS.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>A total of 1590 patients were enrolled; among them, 669 underwent a MPI stress test strategy (sCMR: 287, SPECT-MPI: 382). The incidence of 30-day cardiac events was lower in the stress-tested group compared to the non-stress-tested group (1.2% vs. 3.4%; <i>p</i> 0.006). Adopting a stress test strategy showed a significant reduction in the risk of the composite endpoint (OR: 0.33, 95% CI: 0.15–0.76, <i>p</i> 0.009) and ACS (OR: 0.41, 95% CI: 0.17–0.98, <i>p</i> 0.046) at multivariable analysis, with similar cardiac events rate between stress CMR and SPECT (1.1% vs. 1.3%, <i>p</i> 0.756). Stress CMR showed a greater accuracy to predict coronary artery revascularizations (sCMR c-statistic: 0.95, ischemic cut-point: 5.5%; SPECT c-statistic: 0.85, ischemic cut-point: 7.5%).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Stress test strategy is related to a lower occurrence of cardiac events in high-risk patients scheduled for intermediate-to-high-risk non-cardiac surgeries. Both sCMR and SPECT-MPI comparably reduce the likelihood of cardiac complications, albeit sCMR offers greater accuracy in predicting coronary artery revascularization.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary emphysema: the assessment of lung perfusion with Dual-Energy CT and pulmonary scintigraphy 肺气肿:用双能量 CT 和肺部闪烁扫描评估肺部灌注情况
Pub Date : 2024-09-10 DOI: 10.1007/s11547-024-01883-y
Alessandra Borgheresi, Elisa Cesari, Andrea Agostini, Myriam Badaloni, Sofia Balducci, Elisabetta Tola, Valeria Consoli, Andrea Palucci, Luca Burroni, Marina Carotti, Andrea Giovagnoni

Aim

To assess the correlation of quantitative data of pulmonary Perfused Blood Volume (PBV) on Dual-Energy CT (DECT) datasets in patients with moderate – severe Pulmonary Emphysema (PE) with Lung Perfusion Scintigraphy (LPS) as the reference standard. The secondary endpoints are the correlation between the CT densitometric analysis and the visual assessment of parenchymal destruction with PBV.

Materials and Methods

Patients with moderate – severe PE candidate to Lung Volumetric Reduction (LVR), with available a pre-procedural LS and a contrast-enhanced DECT were retrospectively included. DECT studies were performed with a 3rd generation Dual-Source CT and the PBV was obtained with a 3-material decomposition algorithm. The CT densitometric analysis was performed with a dedicated commercial software (Pulmo3D). The Goddard Score was used for visual assessment. The perfusion LS were performed after the administration of albumin macroaggregates labeled with 99mTechnetium. The image revision was performed by two radiologists or nuclear medicine physicians blinded, respectively, to LS and DECT data. The statistical analysis was performed with nonparametric tests.

Results

Thirty-one patients (18 males, median age 69 y.o., interquartile range 62–71 y.o.) with moderate – severe PE (Median Goddard Score 14/20 and 31% of emphysematous parenchyma at quantitative CT) candidate to LVR were retrospectively included. The median enhancement on PBV was 17 HU. Significant correlation coefficients were demonstrated between lung PBV and LS, poor in apical regions (Rho = 0.1–0.2) and fair (Rho = 0.3–0.5) in middle and lower regions. No significant correlations were recorded between the CT densitometric analysis, the visual score, and the PBV.

Conclusions

Lung perfusion with PBV on DECT is feasible in patients with moderate – severe PE candidate to LVR, and has a poor to fair agreement with LPS.

目的评估中重度肺气肿(PE)患者双能量 CT(DECT)数据集上肺灌注血量(PBV)的定量数据与作为参考标准的肺灌注闪烁成像(LPS)的相关性。材料与方法回顾性纳入了肺容积缩小术(LVR)的中重度肺气肿候选患者,这些患者均有术前LS和对比度增强DECT。DECT 研究使用第三代双源 CT 进行,PBV 使用 3 物质分解算法获得。CT 密度计分析使用专用商业软件 (Pulmo3D) 进行。Goddard 评分用于视觉评估。灌注LS是在使用99m锝标记的白蛋白大颗粒后进行的。图像修改由两名放射科医生或核医学医生分别进行,他们对LS和DECT数据都是盲人。结果回顾性纳入了 31 名中重度 PE 患者(18 名男性,中位年龄 69 岁,四分位数范围 62-71 岁)(中位 Goddard 评分 14/20,定量 CT 显示气肿实质占 31%),他们都是 LVR 候选者。PBV 中位增强值为 17 HU。肺PBV和LS之间存在显著的相关系数,在顶部区域相关系数较低(Rho = 0.1-0.2),在中下部区域相关系数一般(Rho = 0.3-0.5)。结论在中度-重度 PE 患者中,DECT 肺灌注 PBV 与 LVR 是可行的,但与 LPS 的一致性较差至一般。
{"title":"Pulmonary emphysema: the assessment of lung perfusion with Dual-Energy CT and pulmonary scintigraphy","authors":"Alessandra Borgheresi, Elisa Cesari, Andrea Agostini, Myriam Badaloni, Sofia Balducci, Elisabetta Tola, Valeria Consoli, Andrea Palucci, Luca Burroni, Marina Carotti, Andrea Giovagnoni","doi":"10.1007/s11547-024-01883-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01883-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Aim</h3><p>To assess the correlation of quantitative data of pulmonary Perfused Blood Volume (PBV) on Dual-Energy CT (DECT) datasets in patients with moderate – severe Pulmonary Emphysema (PE) with Lung Perfusion Scintigraphy (LPS) as the reference standard. The secondary endpoints are the correlation between the CT densitometric analysis and the visual assessment of parenchymal destruction with PBV.</p><h3 data-test=\"abstract-sub-heading\">Materials and Methods</h3><p>Patients with moderate – severe PE candidate to Lung Volumetric Reduction (LVR), with available a pre-procedural LS and a contrast-enhanced DECT were retrospectively included. DECT studies were performed with a 3rd generation Dual-Source CT and the PBV was obtained with a 3-material decomposition algorithm. The CT densitometric analysis was performed with a dedicated commercial software (Pulmo3D). The Goddard Score was used for visual assessment. The perfusion LS were performed after the administration of albumin macroaggregates labeled with <sup>99m</sup>Technetium. The image revision was performed by two radiologists or nuclear medicine physicians blinded, respectively, to LS and DECT data. The statistical analysis was performed with nonparametric tests.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Thirty-one patients (18 males, median age 69 y.o., interquartile range 62–71 y.o.) with moderate – severe PE (Median Goddard Score 14/20 and 31% of emphysematous parenchyma at quantitative CT) candidate to LVR were retrospectively included. The median enhancement on PBV was 17 HU. Significant correlation coefficients were demonstrated between lung PBV and LS, poor in apical regions (Rho = 0.1–0.2) and fair (Rho = 0.3–0.5) in middle and lower regions. No significant correlations were recorded between the CT densitometric analysis, the visual score, and the PBV.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>Lung perfusion with PBV on DECT is feasible in patients with moderate – severe PE candidate to LVR, and has a poor to fair agreement with LPS.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent trends in AI applications for pelvic MRI: a comprehensive review 人工智能在盆腔磁共振成像中应用的最新趋势:全面回顾
Pub Date : 2024-08-03 DOI: 10.1007/s11547-024-01861-4
Takahiro Tsuboyama, Masahiro Yanagawa, Tomoyuki Fujioka, Shohei Fujita, Daiju Ueda, Rintaro Ito, Akira Yamada, Yasutaka Fushimi, Fuminari Tatsugami, Takeshi Nakaura, Taiki Nozaki, Koji Kamagata, Yusuke Matsui, Kenji Hirata, Noriyuki Fujima, Mariko Kawamura, Shinji Naganawa

Magnetic resonance imaging (MRI) is an essential tool for evaluating pelvic disorders affecting the prostate, bladder, uterus, ovaries, and/or rectum. Since the diagnostic pathway of pelvic MRI can involve various complex procedures depending on the affected organ, the Reporting and Data System (RADS) is used to standardize image acquisition and interpretation. Artificial intelligence (AI), which encompasses machine learning and deep learning algorithms, has been integrated into both pelvic MRI and the RADS, particularly for prostate MRI. This review outlines recent developments in the use of AI in various stages of the pelvic MRI diagnostic pathway, including image acquisition, image reconstruction, organ and lesion segmentation, lesion detection and classification, and risk stratification, with special emphasis on recent trends in multi-center studies, which can help to improve the generalizability of AI.

磁共振成像(MRI)是评估影响前列腺、膀胱、子宫、卵巢和/或直肠的盆腔疾病的重要工具。由于盆腔磁共振成像的诊断路径可能涉及各种复杂的程序,具体取决于受影响的器官,因此报告和数据系统(RADS)被用来规范图像采集和解读。人工智能(AI)包括机器学习和深度学习算法,已被整合到盆腔磁共振成像和 RADS 中,尤其是前列腺磁共振成像。这篇综述概述了人工智能在盆腔 MRI 诊断路径各阶段应用的最新进展,包括图像采集、图像重建、器官和病灶分割、病灶检测和分类以及风险分层,并特别强调了多中心研究的最新趋势,这有助于提高人工智能的普适性。
{"title":"Recent trends in AI applications for pelvic MRI: a comprehensive review","authors":"Takahiro Tsuboyama, Masahiro Yanagawa, Tomoyuki Fujioka, Shohei Fujita, Daiju Ueda, Rintaro Ito, Akira Yamada, Yasutaka Fushimi, Fuminari Tatsugami, Takeshi Nakaura, Taiki Nozaki, Koji Kamagata, Yusuke Matsui, Kenji Hirata, Noriyuki Fujima, Mariko Kawamura, Shinji Naganawa","doi":"10.1007/s11547-024-01861-4","DOIUrl":"https://doi.org/10.1007/s11547-024-01861-4","url":null,"abstract":"<p>Magnetic resonance imaging (MRI) is an essential tool for evaluating pelvic disorders affecting the prostate, bladder, uterus, ovaries, and/or rectum. Since the diagnostic pathway of pelvic MRI can involve various complex procedures depending on the affected organ, the Reporting and Data System (RADS) is used to standardize image acquisition and interpretation. Artificial intelligence (AI), which encompasses machine learning and deep learning algorithms, has been integrated into both pelvic MRI and the RADS, particularly for prostate MRI. This review outlines recent developments in the use of AI in various stages of the pelvic MRI diagnostic pathway, including image acquisition, image reconstruction, organ and lesion segmentation, lesion detection and classification, and risk stratification, with special emphasis on recent trends in multi-center studies, which can help to improve the generalizability of AI.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"75 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141883388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study 基于核磁共振成像的放射组学在舌癌中的预后作用:一项多中心验证研究
Pub Date : 2024-08-03 DOI: 10.1007/s11547-024-01859-y
Marta Tagliabue, Francesca Ruju, Chiara Mossinelli, Aurora Gaeta, Sara Raimondi, Stefania Volpe, Mattia Zaffaroni, Lars Johannes Isaksson, Cristina Garibaldi, Marta Cremonesi, Anna Rapino, Susanna Chiocca, Giacomo Pietrobon, Daniela Alterio, Giuseppe Trisolini, Patrizia Morbini, Vittorio Rampinelli, Alberto Grammatica, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa, Lorenzo Preda, Marco Ravanelli, Roberto Maroldi, Cesare Piazza, Marco Benazzo, Mohssen Ansarin

Purpose

Radiomics is an emerging field that utilizes quantitative features extracted from medical images to predict clinically meaningful outcomes. Validating findings is crucial to assess radiomics applicability. We aimed to validate previously published magnetic resonance imaging (MRI) radiomics models to predict oncological outcomes in oral tongue squamous cell carcinoma (OTSCC).

Materials and methods

Retrospective multicentric study on OTSCC surgically treated from 2010 to 2019. All patients performed preoperative MRI, including contrast-enhanced T1-weighted (CE-T1), diffusion-weighted sequences and apparent diffusion coefficient map. We evaluated overall survival (OS), locoregional recurrence-free survival (LRRFS), cause-specific mortality (CSM). We elaborated different models based on clinical and radiomic data. C-indexes assessed the prediction accuracy of the models.

Results

We collected 112 consecutive independent patients from three Italian Institutions to validate the previously published MRI radiomic models based on 79 different patients. The C-indexes for the hybrid clinical-radiomic models in the validation cohort were lower than those in the training cohort but remained > 0.5 in most cases. CE-T1 sequence provided the best fit to the models: the C-indexes obtained were 0.61, 0.59, 0.64 (pretreatment model) and 0.65, 0.69, 0.70 (posttreatment model) for OS, LRRFS and CSM, respectively.

Conclusion

Our clinical-radiomic models retain a potential to predict OS, LRRFS and CSM in heterogeneous cohorts across different centers. These findings encourage further research, aimed at overcoming current limitations, due to the variability of imaging acquisition, processing and tumor volume delineation.

目的 放射组学是一个新兴领域,它利用从医学影像中提取的定量特征来预测具有临床意义的结果。验证研究结果对于评估放射组学的适用性至关重要。我们旨在验证之前发表的磁共振成像(MRI)放射组学模型,以预测口腔舌鳞状细胞癌(OTSCC)的肿瘤预后。所有患者均进行了术前 MRI 检查,包括对比增强 T1 加权(CE-T1)、弥散加权序列和表观弥散系数图。我们评估了总生存率(OS)、无局部复发生存率(LRRFS)和特异性死亡率(CSM)。我们根据临床和放射学数据建立了不同的模型。结果我们从意大利三家机构收集了112名连续的独立患者,对之前发表的基于79名不同患者的磁共振成像放射学模型进行了验证。验证队列中临床-放射学混合模型的 C 指数低于训练队列中的 C 指数,但在大多数情况下仍为 > 0.5。CE-T1序列为模型提供了最佳拟合度:对于OS、LRRFS和CSM,获得的C指数分别为0.61、0.59、0.64(治疗前模型)和0.65、0.69、0.70(治疗后模型)。这些发现鼓励了进一步的研究,旨在克服目前由于成像采集、处理和肿瘤体积划分的可变性而造成的局限性。
{"title":"The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study","authors":"Marta Tagliabue, Francesca Ruju, Chiara Mossinelli, Aurora Gaeta, Sara Raimondi, Stefania Volpe, Mattia Zaffaroni, Lars Johannes Isaksson, Cristina Garibaldi, Marta Cremonesi, Anna Rapino, Susanna Chiocca, Giacomo Pietrobon, Daniela Alterio, Giuseppe Trisolini, Patrizia Morbini, Vittorio Rampinelli, Alberto Grammatica, Giuseppe Petralia, Barbara Alicja Jereczek-Fossa, Lorenzo Preda, Marco Ravanelli, Roberto Maroldi, Cesare Piazza, Marco Benazzo, Mohssen Ansarin","doi":"10.1007/s11547-024-01859-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01859-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Radiomics is an emerging field that utilizes quantitative features extracted from medical images to predict clinically meaningful outcomes. Validating findings is crucial to assess radiomics applicability. We aimed to validate previously published magnetic resonance imaging (MRI) radiomics models to predict oncological outcomes in oral tongue squamous cell carcinoma (OTSCC).</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>Retrospective multicentric study on OTSCC surgically treated from 2010 to 2019. All patients performed preoperative MRI, including contrast-enhanced T1-weighted (CE-T1), diffusion-weighted sequences and apparent diffusion coefficient map. We evaluated overall survival (OS), locoregional recurrence-free survival (LRRFS), cause-specific mortality (CSM). We elaborated different models based on clinical and radiomic data. C-indexes assessed the prediction accuracy of the models.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>We collected 112 consecutive independent patients from three Italian Institutions to validate the previously published MRI radiomic models based on 79 different patients. The C-indexes for the hybrid clinical-radiomic models in the validation cohort were lower than those in the training cohort but remained &gt; 0.5 in most cases. CE-T1 sequence provided the best fit to the models: the C-indexes obtained were 0.61, 0.59, 0.64 (pretreatment model) and 0.65, 0.69, 0.70 (posttreatment model) for OS, LRRFS and CSM, respectively.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our clinical-radiomic models retain a potential to predict OS, LRRFS and CSM in heterogeneous cohorts across different centers. These findings encourage further research, aimed at overcoming current limitations, due to the variability of imaging acquisition, processing and tumor volume delineation.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141883391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photon-counting detector computed tomography for metal artifact reduction: a comparative study of different artifact reduction techniques in patients with orthopedic implants 用于减少金属伪影的光子计数探测器计算机断层扫描:对骨科植入物患者采用不同伪影减少技术的比较研究
Pub Date : 2024-04-30 DOI: 10.1007/s11547-024-01822-x
Fabian Bernhard Pallasch, Alexander Rau, Marco Reisert, Stephan Rau, Thierno Diallo, Thomas Stein, Sebastian Faby, Fabian Bamberg, Jakob Weiss

Purpose

Artifacts caused by metallic implants remain a challenge in computed tomography (CT). We investigated the impact of photon-counting detector computed tomography (PCD-CT) for artifact reduction in patients with orthopedic implants with respect to image quality and diagnostic confidence using different artifact reduction approaches.

Material and methods

In this prospective study, consecutive patients with orthopedic implants underwent PCD-CT imaging of the implant area. Four series were reconstructed for each patient (clinical standard reconstruction [PCD-CTStd], monoenergetic images at 140 keV [PCD-CT140keV], iterative metal artifact reduction (iMAR) corrected [PCD-CTiMAR], combination of iMAR and 140 keV monoenergetic [PCD-CT140keV+iMAR]). Subsequently, three radiologists evaluated the reconstructions in a random and blinded manner for image quality, artifact severity, anatomy delineation (adjacent and distant), and diagnostic confidence using a 5-point Likert scale (5 = excellent). In addition, the coefficient of variation [CV] and the relative quantitative artifact reduction potential were obtained as objective measures.

Results

We enrolled 39 patients with a mean age of 67.3 ± 13.2 years (51%; n = 20 male) and a mean BMI of 26.1 ± 4 kg/m2. All image quality measures and diagnostic confidence were significantly higher for the iMAR vs. non-iMAR reconstructions (all p < 0.001). No significant effect of the different artifact reduction approaches on CV was observed (p = 0.26). The quantitative analysis indicated the most effective artifact reduction for the iMAR reconstructions, which was higher than PCD-CT140keV (p < 0.001).

Conclusion

PCD-CT allows for effective metal artifact reduction in patients with orthopedic implants, resulting in superior image quality and diagnostic confidence with the potential to improve patient management and clinical decision making.

目的 金属植入物造成的伪影仍然是计算机断层扫描(CT)的一项挑战。我们研究了光子计数探测器计算机断层扫描(PCD-CT)在骨科植入物患者中使用不同的减少伪影方法对图像质量和诊断信心的影响。对每位患者进行了四组重建(临床标准重建[PCD-CTStd]、140 keV 单能量图像[PCD-CT140keV]、迭代金属伪影减少(iMAR)校正[PCD-CTiMAR]、iMAR 和 140 keV 单能量图像组合[PCD-CT140keV+iMAR])。随后,三位放射科医生采用随机和盲法对重建图像的质量、伪影严重程度、解剖结构划分(邻近和远处)以及诊断信心进行评估,评估采用李克特五点量表(5 = 优秀)。此外,还获得了变异系数[CV]和相对定量减少伪影的潜力作为客观指标。iMAR 重建与非 iMAR 重建相比,所有图像质量指标和诊断可信度都明显更高(所有 p 均为 0.001)。不同的伪影消除方法对 CV 没有明显影响(p = 0.26)。定量分析显示,iMAR 重建最有效地减少了伪影,高于 PCD-CT140keV (p < 0.001)。
{"title":"Photon-counting detector computed tomography for metal artifact reduction: a comparative study of different artifact reduction techniques in patients with orthopedic implants","authors":"Fabian Bernhard Pallasch, Alexander Rau, Marco Reisert, Stephan Rau, Thierno Diallo, Thomas Stein, Sebastian Faby, Fabian Bamberg, Jakob Weiss","doi":"10.1007/s11547-024-01822-x","DOIUrl":"https://doi.org/10.1007/s11547-024-01822-x","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>Artifacts caused by metallic implants remain a challenge in computed tomography (CT). We investigated the impact of photon-counting detector computed tomography (PCD-CT) for artifact reduction in patients with orthopedic implants with respect to image quality and diagnostic confidence using different artifact reduction approaches.</p><h3 data-test=\"abstract-sub-heading\">Material and methods</h3><p>In this prospective study, consecutive patients with orthopedic implants underwent PCD-CT imaging of the implant area. Four series were reconstructed for each patient (clinical standard reconstruction [PCD-CT<sub>Std</sub>], monoenergetic images at 140 keV [PCD-CT<sub>140keV</sub>], iterative metal artifact reduction (iMAR) corrected [PCD-CT<sub>iMAR</sub>], combination of iMAR and 140 keV monoenergetic [PCD-CT<sub>140keV+iMAR</sub>]). Subsequently, three radiologists evaluated the reconstructions in a random and blinded manner for image quality, artifact severity, anatomy delineation (adjacent and distant), and diagnostic confidence using a 5-point Likert scale (5 = excellent). In addition, the coefficient of variation [CV] and the relative quantitative artifact reduction potential were obtained as objective measures.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>We enrolled 39 patients with a mean age of 67.3 ± 13.2 years (51%; n = 20 male) and a mean BMI of 26.1 ± 4 kg/m<sup>2</sup>. All image quality measures and diagnostic confidence were significantly higher for the iMAR vs. non-iMAR reconstructions (all <i>p</i> &lt; 0.001). No significant effect of the different artifact reduction approaches on CV was observed (<i>p</i> = 0.26). The quantitative analysis indicated the most effective artifact reduction for the iMAR reconstructions, which was higher than PCD-CT<sub>140keV</sub> (<i>p</i> &lt; 0.001).</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>PCD-CT allows for effective metal artifact reduction in patients with orthopedic implants, resulting in superior image quality and diagnostic confidence with the potential to improve patient management and clinical decision making.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"123 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140826834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network 中型地中海贫血症患者的多参数心脏磁共振:E-MIOT 网络的新发现
Pub Date : 2024-04-29 DOI: 10.1007/s11547-024-01821-y
Antonella Meloni, Laura Pistoia, Paolo Ricchi, Filomena Longo, Valerio Cecinati, Francesco Sorrentino, Liana Cuccia, Elisabetta Corigliano, Vincenza Rossi, Riccardo Righi, Priscilla Fina, Stefania Renne, Luigi Barbuto, Vincenzo Positano, Filippo Cademartiri

Purpose

In a relatively large cohort of thalassemia intermedia (TI) patients, we systematically investigated myocardial iron overload (MIO), function, and replacement fibrosis using cardiac magnetic resonance (CMR), we assessed the clinical determinants of global heart T2* values, and we explored the association between multiparametric CMR findings and cardiac complications.

Materials and methods

We considered 254 beta-TI patients (43.14 ± 13.69 years, 138 females) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia project. MIO was quantified by T2* technique and biventricular function and atrial areas by cine images. Macroscopic myocardial fibrosis was detected by late gadolinium enhancement technique.

Results

Compared to never/sporadically transfused patients, regularly transfused (RT)-TI patients exhibited significantly lower global heart T2* values, biventricular end-diastolic volume indexes, left ventricular mass index, and cardiac index. In RT-TI patients, age and serum ferritin levels were the strongest predictors of global heart T2* values. Independently from the transfusional state, cardiac T2* values were not associated with biventricular function.

Of the 103 (40.6%) patients in whom the contrast medium was administrated, 27 (26.2%) had replacement myocardial fibrosis. Age, sex distribution, cardiac iron, and biventricular function parameters were comparable between patients without and without replacement myocardial fibrosis. Twenty-five (9.8%) patients had a history of cardiac complications (heart failure and arrhythmias). Increased age and replacement myocardial fibrosis emerged as significant risk markers for cardiac complications.

Conclusions

In TI, regular transfusions are associated with less pronounced cardiac remodeling but increase the risk of MIO. Replacement myocardial fibrosis is a frequent finding associated with cardiac complications.

目的 在一个相对较大的中型地中海贫血(TI)患者队列中,我们使用心脏磁共振(CMR)系统地研究了心肌铁超载(MIO)、功能和替代纤维化,评估了整体心脏 T2* 值的临床决定因素,并探讨了多参数 CMR 结果与心脏并发症之间的关联。材料和方法我们考虑了连续加入地中海贫血扩展-心肌铁过载项目的 254 名β-TI 患者(43.14 ± 13.69 岁,138 名女性)。通过 T2* 技术对 MIO 进行量化,并通过 cine 图像对双心室功能和心房区域进行量化。结果与从未/偶尔输血的患者相比,定期输血(RT)-TI 患者的全心 T2* 值、双心室舒张末期容积指数、左心室质量指数和心脏指数均显著降低。在 RT-TI 患者中,年龄和血清铁蛋白水平是预测总体心脏 T2* 值的最主要因素。在 103 例(40.6%)使用造影剂的患者中,27 例(26.2%)有替代性心肌纤维化。无替代性心肌纤维化和无替代性心肌纤维化患者的年龄、性别分布、心肌铁和双心室功能参数相当。25名患者(9.8%)有心脏并发症(心力衰竭和心律失常)病史。结论 在 TI 中,定期输血与较不明显的心脏重塑有关,但会增加 MIO 的风险。替代性心肌纤维化是与心脏并发症相关的一个常见发现。
{"title":"Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network","authors":"Antonella Meloni, Laura Pistoia, Paolo Ricchi, Filomena Longo, Valerio Cecinati, Francesco Sorrentino, Liana Cuccia, Elisabetta Corigliano, Vincenza Rossi, Riccardo Righi, Priscilla Fina, Stefania Renne, Luigi Barbuto, Vincenzo Positano, Filippo Cademartiri","doi":"10.1007/s11547-024-01821-y","DOIUrl":"https://doi.org/10.1007/s11547-024-01821-y","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>In a relatively large cohort of thalassemia intermedia (TI) patients, we systematically investigated myocardial iron overload (MIO), function, and replacement fibrosis using cardiac magnetic resonance (CMR), we assessed the clinical determinants of global heart T2* values, and we explored the association between multiparametric CMR findings and cardiac complications.</p><h3 data-test=\"abstract-sub-heading\">Materials and methods</h3><p>We considered 254 beta-TI patients (43.14 ± 13.69 years, 138 females) consecutively enrolled in the Extension-Myocardial Iron Overload in Thalassemia project. MIO was quantified by T2* technique and biventricular function and atrial areas by cine images. Macroscopic myocardial fibrosis was detected by late gadolinium enhancement technique.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Compared to never/sporadically transfused patients, regularly transfused (RT)-TI patients exhibited significantly lower global heart T2* values, biventricular end-diastolic volume indexes, left ventricular mass index, and cardiac index. In RT-TI patients, age and serum ferritin levels were the strongest predictors of global heart T2* values. Independently from the transfusional state, cardiac T2* values were not associated with biventricular function.</p><p>Of the 103 (40.6%) patients in whom the contrast medium was administrated, 27 (26.2%) had replacement myocardial fibrosis. Age, sex distribution, cardiac iron, and biventricular function parameters were comparable between patients without and without replacement myocardial fibrosis. Twenty-five (9.8%) patients had a history of cardiac complications (heart failure and arrhythmias). Increased age and replacement myocardial fibrosis emerged as significant risk markers for cardiac complications.</p><h3 data-test=\"abstract-sub-heading\">Conclusions</h3><p>In TI, regular transfusions are associated with less pronounced cardiac remodeling but increase the risk of MIO. Replacement myocardial fibrosis is a frequent finding associated with cardiac complications.</p>","PeriodicalId":501689,"journal":{"name":"La radiologia medica","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140813010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
La radiologia medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1